30 closest matches · ranked by relevance
Emphysema
Primary: Count of Patients With Grade 3 or Higher Adverse Events. — 3 Participants
Lung Neoplasms
Primary: Discharge 2weeks Exercise Capacity — 408.61; 311.94 meter(M) — p=<0.05
Lung Cancer
Primary: Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0 — 1 Participants
Lung; Node
Primary: Number of Participants With Device or Procedure Related Adverse Events — 2 Participants
Lung Cancer · Complication of Surgical Procedure
Primary: Postoperative Chest Drainage Volume up to Chest Drain Removal, Average 3 Days. — 550; 580 ml
Non Small Cell Lung Cancer
Primary: Incidence of Intra-Operative Hemostatic Intervention — 0.0533; 0.0833 Proportion transections w/ intervention
Lung Disease · Pulmonary Lobectomy
Primary: Percentage of Subjects Remaining Air Leak Free From Time of Skin Closure to Hospital Discharge. — 41.9; 30.5 Percentage of participants — p=0.257
Video-assisted Thoracoscopic Surgery · Lung Isolation Device · One-lung Ventilation
Primary: Time to Obtain Complete Lung Collapse — 47.8; 32.5 minutes
Non-Small Cell Lung Cancer
Primary: Incidence of Intra-Operative Hemostatic Interventions — 1.8 Percentage of vessel transections
Pulmonary Stenosis · Pulmonary Regurgitation · Tetralogy of Fallot
Primary: Successful Repair of Conduit Disruption — 48 participants
Lung Cancer
Primary: Exercise Tolerance — 459.7; 341 Seconds
Idiopathic Pulmonary Fibrosis · Gastroesophageal Reflux
Primary: Forced Vital Capacity (FVC) — -0.13; -0.05 liters
Brain Ischemia · Reduction of Cerebral Air Emboli
Primary: Quantitative Assessment of Air Embolism to the Brain After Completion of Open Left Heart Surgery — 46; 32 gaseous cerebral microemboli — p=1.00
Non-small Cell Lung Cancer (NSCLC)
Primary: Occurrence of Postoperative Air Leaks — 45.8; 67.9; 88.9 percentage of participants
Lung Cancer
Primary: Incidence of Prolonged Air Leaks — 5 participants
Peripheral Pulmonary Nodules
Primary: Feasibility — 24 participants
Lung Nodule
Primary: Diagnostic Accuracy — 94; 81 Participants — p=0.003
Emphysema
Primary: Forced Expiratory Volume in 1-second (FEV1) — 61; 10 Participants
Non-small Cell Lung Cancer (NSCLC)
Primary: Occurrence of Prolonged Air Leaks — 0.0; 5.8; 37.5 percentage of participants
Lung Cancer · Pulmonary Nodule, Solitary · Segmentectomy
Primary: The Intersegmental Border Appearance Time During the Surgery. — 748.74; 157.11 seconds
Obesity
Primary: Time Taken for Endotracheal Tube Placement Procedure. — 3.4; 4.1 minutes
Lung Cancer · Lung Cancer Metastatic
Primary: Safety: Number of Participants With at Least One Adverse Event — 10 Participants — p=<0.05
Pulmonary Disease
Primary: Rate of Device and/or Procedure-related Adverse Events — 42.5 percentage of participants
Morbid Obesity
Primary: Change in Body Weight — -21.4; -36.6; -7.0 kg
Antibiotic Prophylaxis
Primary: Number of Participants Who Experienced At Least One Postoperative Infectious Complication — 13; 8 Participants — p=.26
Pulmonary Valve Insufficiency · Pulmonary Valve Degeneration · Congenital Pulmonary Valve Abnormality
Primary: Percentage of Subject's With Freedom From Device or Procedure Related Death and/or Reoperation at 1-year Post-implant. — 100.0 percentage of subjects
Peripheral Solitary Pulmonary Nodule or Tuberculoma
Primary: Comparing the Inflammatory Markers During the Operation After the Intervention of the Each Group — 33; 35; 39; 42 pg/L — p=0.025
Cardiovascular Diseases · Thoracic Diseases · Surgery
Primary: Adherence to Respiratory Strength Training — 35750 Repetitions
Lung Cancer
Primary: The Difference of Diagnostic Value of ENB-GS-TBLB as Compared to GS-TBLB — 34; 25; 5; 16 participants — p=0.019
Thoracic Injuries
Primary: Number of Double Lumen Tube (DLT) or Bronchial Blocker (BB) Replacements — 13; 14; 14; 13 Number of replacements